Skip to main content
Alex Spyropoulos, MD, Oncology, New York, NY, Huntington Hospital

AlexCSpyropoulosMDFACP, FCCP, FRCPC

Oncology New York, NY

Professor of Medicine, Hofstra North Shore/LIJ School of Medicine, Director - Anticoagulation and Clinical Thrombosis Services, North Shore/LIJ Health System at Lenox Hill Hospital

Dr. Spyropoulos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Spyropoulos' full profile

Already have an account?

Education & Training

  • University of New Mexico School of Medicine
    University of New Mexico School of MedicineResidency, Internal Medicine, 1992 - 1995
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1992

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2011 - 2025
  • NM State Medical License
    NM State Medical License 1992 - 2024
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Fellow (FACP) American College of Physicians, 2001

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Treatment of Venous Thromboembolism in Elite Athletes: A Suggested Approach to Individualized Anticoagulation  
    Alex C Spyropoulos, Craig M Kessler, Bhavi Pandya, Seminars in Thrombosis and Hemostasis

Abstracts/Posters

  • Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study
    Alex Spyropoulos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Increased Risk of Death in Acutely Ill Medical Patients with Asymptomatic Proximal Deep Vein Thrombosis or Symptomatic Venous Thromboembolism: Insights from the Magell...
    Alex C. Spyropoulo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Rivaroxaban and Extended Thromboprophylaxis in Acutely Ill Medical Patients with History of Cancer: Insights from the Magellan and Mariner Studies 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Join now to see all

Press Mentions

  • COVID-19 Patients with Cardiovascular Disease More Likely to Develop Blood Clots Post-Hospital Discharge, Feinstein Institutes Study
    COVID-19 Patients with Cardiovascular Disease More Likely to Develop Blood Clots Post-Hospital Discharge, Feinstein Institutes StudyMay 23rd, 2023
  • Virtual, Cloud-Based PREVENT-HD Trial Evaluates Rivaroxaban To Prevent Thrombosis in COVID-19 Patients
    Virtual, Cloud-Based PREVENT-HD Trial Evaluates Rivaroxaban To Prevent Thrombosis in COVID-19 PatientsMay 16th, 2023
  • Feature | Science Highlights from AHA 2022
    Feature | Science Highlights from AHA 2022December 2nd, 2022
  • Join now to see all

Professional Memberships

Hospital Affiliations